mpMRIs, MRI/TRUS fusion-guided biopsies, and systematic biopsies in monitoring of men on active surveillance

A new article in the Journal of Urology has provided us with some initial insight into the value of multiparametric MRIs (mpMRIs) in monitoring progression of patients on active surveillance protocols. … READ MORE …

Refining the criteria for selection of patients suitable for active surveillance

The question of how best to set the spectrum of criteria that indicate the suitability of an individual patient as a good candidate for active surveillance as opposed to early treatment is (as yet) not well answered. … READ MORE …

Tales from “a poster boy” for active surveillance

Howard Wolinksy is  a journalist — by training and by profession. In 2010, a while after he finished full-time employment with the Chicago Sun-Times, he was diagnosed with low-risk prostate cancer, and he has been documenting the impact ever since. … READ MORE …

The role of active surveillance in prostate cancer management today

There is a new and very sound article by Gina Kolata in The New York Times (published online yesterday) addressing the expanding role of active surveillance as an initial management option for low-risk forms of prostate cancer. … READ MORE …

Active surveillance and African-American ethnicity

There have been reports in the recent past that active surveillance may be less appropriate for African-American men than it is for others; and then there have been reports that did not show such an effect. … READ MORE …

Active surveillance studies can have highly informative results — even when poorly executed!

The Göteborg group in Sweden have just published long-term follow-up data on the management of > 450 men identified with very low-, low-, and intermediate-risk prostate cancer as a consequence of the Gotebörg screening trial and managed on something they call “active surveillance” … READ MORE …

Another Sunnybrook update: risk for metastasis on active surveillance

The Sunnybrook Group from the University of Toronto in Canada have just provided us with yet another update on the outcomes of their cohort of 980 patients managed initially on active surveillance and dating back to 1996. … READ MORE …